Diagnostic standards and classification of tuberculosis in adults and children

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 4 I, 2000, Pages 1376-1395

  Dunlap, Nancy E ^a   Bass, John ^a   Fujiwara, Paula ^a   Hopewell, Philip ^a   Horsburgh Jr , C Robert ^a   Salfinger, Max ^a   Simone, Patricia M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM IDENTIFICATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULIN TEST;

EID: 0034058883     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.4.16141     Document Type: Review

References (161)

1. World Health Organisation. 1996. Groups at Risk: WHO Report on the Tuberculosis Epidemic. World Health Organization, Geneva, Switzerland.
2. Sudrc, P., G. T. Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. World Health Org. 70:149-159.
3. Starke, J., R. Jacobs, and J. Jereb. 1992. Resurgence of tuberculosis in children. J. Pediatr. 120:839-855.
4. Edwards, D., and C. H. Kirkpatrick. 1986. The immunology of mycobacterial diseases. Am. Rev. Respir. Dis. 134:1062-1071.
5. Riley, R. 1993. Transmission and environmental control of tuberculosis. In L. Reichman and E. Hershfield, editors. Tuberculosis. Marcel Deckker, New York.
6. Riley, R. 1974. Airborne infection. Am. J. Med. 57:466-475.
7. Murray, J. 1986. Chapter 13: Defense mechanisms. In J. F. Murray, editor. The Normal Lung: The Basis for Diagnosis and Treatment of Pulmonary Disease. W. B. Saunders, Philadelphia, PA. 313-338.
8. Horsburgh, J. 1996. Tuberculosis without tubercles. Tuberc. Lung Dis. 77:197-198.
9. Centers for Disease Control and Prevention. 1994. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare facilities. MMWR 43(RR-13).
10. Jindani, A., E. Aber, E. Edwards, and D. Milchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121:939-949.
11. van Soolingcn, D., T. Hoogenboezem, P. E. W. De Haas, P. W. M. Hermans, M. A. Koedam, K. S. Teppema, P. J. Brennan, G. S. Besra, F. Portaels, J. Top, L. M. Schouls, and J. D. A. van Embden. 1997. A novel pathogenic taxon of the Mycobacterium tuberculosis complex. Canetti: characterization of an exceptional isolate from Africa. Int. J. Syst. Bacteriol. 47:1236-1245.
12. van Soolingen, D., A. G. M. van der Zanden, P. E. W. De Haas, G. T. Noordhoek, A. Kiers, N. A. Foudraine, F. Portaels, A. H. J. Kolk, K. Kremer, and J. D. A. van Embden. 1998. Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J. Clin. Microbiol. 36:1840-1845.
13. O'Reilly, L., and C. Daborn. 1995. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuberc. Lung Dis. 76(Suppl. 1):1-46.
14. Danker, W. M., N. Waecker, M. Essey, K. Moser, M. Thompson, and C. Davis. 1993. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine 72:11-37.
15. Cosivi, O., J. M. Grange, C. J. Daborn, M. C. Raviglione, T. Fujikura, D. Cousins, R. A. Robinson, H. F. A. K. Huchzermeyer, I. de Kantor, and F. X. Meslin. 1998. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerging Infect. Dis. 4:59-70.
16. Grange, J. M., and M. D. Yates. 1989. Incidence and nature of human tuberculosis due to Mycobacterium africanum in South-East England: 1977-87. Epidemiology and Infection 103:127-132.
17. Scully, R. E., E. J. Mark, W. F. McNeeley, and S. H. Ebeling. 1998. Case records of the Massachusetts General Hospital: case 29-1998. N. Engl. J. Med. 339:831-838.
18. Dannenberg, A. M. 1989. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev. Infect. Dis. 11:S369-S378.
19. Dannenberg, A. M. 1992. Pathogenesis of pulmonary tuberculosis: host-parasite interactions, cell-mediated immunity, and delayed-type hypersensitivity. In D. Schlossberg, editor. Basic Principles in Tuberculosis, 3rd ed. Springer-Verlag, New York.
20. Smith, D., and E. Wiengeshaus. 1989. What animal models can teach us about the pathogenesis of tuberculosis in humans. Rev. Infect. Dis. 11:S385-S393.
21. Reggiardo, Z., and G. Middlebrook. 1974. Failure of passive serum transfer of immunity against aerogenic tuberculosis in guinea pigs. Proc. Soc. Exp. Biol Med. 145:173-175.
22. Canetti, G. 1955. The Tubercle Bacillus in the Pulmonary Lesion of Man. Springer-Verlag, New York.
23. Styblo, K. 1991. Epidemiology of Tuberculosis. Royal Netherlands Tuberculosis Association Selected Papers. Royal Netherlands Tuberculosis Association, The Hague.
24. Daley, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, Jr., and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N. Engl. J. Med. 326:231-235.
25. Selwyn, P., D. Hartel, V. Lewis, E. Schoenbaum, S. Vermund, R. Klein, A. Walker, and G. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550.
26. Markowitz, N., N. I. Hansen, T. C. Wilcosky, P. C. Hopewell, J. Glassroth, P. A. Kvale, B. T. Mangura, D. Osmond, J. M. Wallace, M. J. Rosen, and L. B. Reichman. 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119:185-193.
27. Small, P. M., R. W. Shafer, P. C. Hopewell, S. P. Singh, M. J. Murphy, E. Desmond, M. F. Sierra, and G. K. Schoolnik. 1993. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV disease. N. Engl. J. Med. 328:1137-1144.
28. Nardell, E., B. McInnis, B. Thomas, and S. Weidhaas. 1986. Exogenous reinfection with tuberculosis in a shelter for the homeless. N. Engl. J. Med. 315:1570-1575.
29. Stead, W. W., J. P. Lofgren, E. Warren, and C. Thomas. 1985. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N. Engl. J. Med. 312: 1483-1487.
30. Farer, L. S., L. M. Lowell, and M. P. Meador. 1979. Extrapulmonary tuberculosis in the United States. Am. J. Epidemiol. 109:205-217.
31. Small, P. M., G. F. Schecter, P. C. Goodman, M. A. Sande, R. E. Chaisson, and P. C. Hopewell. 1991. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 324:289-294.
32. Jones, B., S. Young, D. Antoniskis, P. Davidson, F. Kramer, and P. Barnes. 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148:1292-1297.
33. Arango, L., A. W. Brewin, and J. F. Murray. 1978. The spectrum of tuberculosis as currently seen in a metropolitan hospital. Am. Rev. Respir. Dis. 108:805-812.
34. Kiblawi, S. S. O., S. J. Jay, R. B. Stonehill, and J. Norton. 1981. Fever response of patients on therapy for pulmonary tuberculosis. Am. Rev. Respir. Dis. 123:20-24.
35. Cameron, S. J. 1974. Tuberculosis and the blood. Tubercle 55:55-72.
36. Carr, W. P. J., R. A. Kyle, and E. J. W. Bowie. 1964. Hematologic changes in tuberculosis. Am. J. Med. Sci. 248:709-714.
37. Chung, D. K., and W. W. Hubbard. 1969. Hyponatremia in untreated active pulmonary tuberculosis. Am. Rev. Repir. Dis. 99:592-597.
38. Vorken, H., S. G. Massy, R. Fallat, L. Kaplan, and C. R. Kleeman. 1970. Antidiuretic principle in tuberculous lung tissue of a patient with pulmonary tuberculosis and hyponatremia. Ann. Intern. Med. 72:383-387.
39. Kramer, F. T., A. R. Modelewsky, A. R. Walinay, J. M. Leedom, and P. F. Barnes. 1990. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am. J. Med. 89:451-456.
40. Murray, H., C. Tuazon, N. Kirmani, and J. Sheagren. 1978. The adult respiratory distress syndrome associated with miliary tuberculosis. Chest 73:37-43.
41. Huseby, J. S., and L. D. Hudson. 1976. Miliary tuberculosis and the adult respiratory distress syndrome. Ann. Intern. Med. 85:609-611.
42. Grzybowski, S., H. Fishault, J. Rowe, and A. Brown. 1971. Tuberculosis among patients with various radiologic abnormalities followed by the chest clinic service. Am. Rev. Respir. Dis. 104:605-608.
43. Stead, W. W., G. R. Kerby, D. P. Schlueter, and C. W. Jordahl. 1968. The clinical spectrum of primary tuberculosis in adults: confusion with reinfection in the pathogenesis of chronic tuberculosis. Ann. Intern. Med. 68:731-745.
44. Chaisson, R. E., G. F. Schecter, C. P. Theuer, G. W. Rutherford. D. F. Echenberg, and P. C. Hopewell. 1987. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy and survival. Am. Rev. Respir. Dis. 136:570-574.
45. Pitchenik, A. E., and H. A. Rubinson. 1985. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am. Rev. Respir. Dis. 131:393-396.
46. Alvarez, S., and W. R. McCabe. 1984. Extrapulmonary tuberculosis re-visited: a review of experience at Boston City and other hospitals. Medicine 63:25-55.
47. Weir, M. R., and G. R. Thornton. 1985. Extrapulmonary tuberculosis: experience of a community hospital and review of the literature. Am. J. Med. 79:467-478.
48. Grieco, M. H., and H. Chmel. 1974. Acute disseminated tuberculosis as a diagnostic problem. Am. Rev. Respir. Dis. 109:554-560.
49. Munt, P. W. 1971. Miliary tuberculosis in the chemotherapy era with a clinical review in 69 American adults. Medicine 51:139-155.
50. Prout, S., and S. R. Benatar. 1980. Disseminated tuberculosis: a study of 62 cases. S. Afr. Med. J. 58:835-842.
51. Sahn, S., and T. Neff. 1974. Miliary tuberculosis. Am. J. Med. 56:495-505.
52. Slavin, R. E., T. J. Walsh, and A. D. Pollack. 1980. Late generalized tuberculosis: a clinical pathologic analysis of 100 cases in the preantibiotic and antibiotic eras. Medicine 59:352-366.
53. Massaro, D., S. Katz, and M. Sachs. 1964. Choroidal tubercles: a clue to hematogenous tuberculosis. Ann. Intern. Med. 60:231-241.
54. Kent, D. C. 1967. Tuberculous lymphadenitis: not a localized disease process. Am. J. Med. Sci. 254:866-874.
55. Berger, H. W., and E. Mejia. 1973. Tuberculous pleurisy. Chest 63:88-92.
56. Elmer, J. J. 1978. Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann. Intern. Med. 89:932-933.
57. Stead, W. W., A. Eichenholtz, and H. K. Strauss. 1955. Operative and pathologic findings in 24 patients with the syndrome of idiopathic pleurisy with effusion presumably tuberculous. Am. Rev. Respir. Dis. 71:473-502.
58. Johnson, T. M., W. McCann, and W. Davey. 1973. Tuberculous bronchopleural fistula. Am. Rev. Respir. Dis. 107:30-41.
59. Christensen, W. I. 1974. Genitourinary tuberculosis: review of 102 cases. Medicine 53:377-390.
60. Simon, H. B., A. J. Weinstein, M. S. Pasternak, M. N. Swartz, and L. J. Lunz. 1977. Genitourinary tuberculosis: clinical features in a general hospital. Am. J. Med. 63:410-420.
61. Lattimer, J. K. 1965. Renal tuberculosis. N. Engl. J. Med. 273:208-211.
62. Berney, S., M. Goldstein, and F. Bishko. 1972. Clinical and diagnostic features of tuberculous arthritis. Am. J. Med. 53:36-42.
63. Gutman, L. 1993. Extrapulmonary tuberculosis. Semin. Pediatr. Infect. Dis. 4:250-260.
64. Auerbach, O. 1951. Tuberculous meningitis: correlation of therapeutic results with the pathogenesis and pathologic changes: II. Pathologic changes in untreated and treated cases. Am. Rev. Tuberc. 64:419-429.
65. Damergis, J. A., E. Leftwich, J. Curtin, and P. Witorsch. 1979. Tuberculoma of the brain. J.A.M.A. 239:413-415.
66. Bhansali, S. K. 1977. Abdominal tuberculosis: experience with 300 cases. Am. J. Gastroenterol. 67:324-337.
67. Borhanmanesh, R., K. Hekmat, K. Vaezzadeh, and H. R. Rezai. 1972. Tuberculous peritonitis: prospective study of 32 cases in Iran. Ann. Intern. Med. 76:567-572.
68. Burack, W. R., and R. M. Hollister. 1960. Tuberculous peritonitis: a study of forty-seven proved cases encountered by a general medical unit in twenty-five years. Am. J. Med. 28:510-523.
69. Singh, M. M., A. M. Bhargova, and K. P. Jain. 1968. Tuberculous peritonitis: an evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N. Engl. J. Med. 281:1091-1094.
70. Harvey, A. M., and M. R. Whitehill. 1937. Tuberculous pericarditis, Medicine 16:45-94.
71. Rooney, J. J., J. A. Crocco, and H. H. Lyons. 1970. Tuberculous peri-carditis. Ann. Intern. Med. 72:73-78.
72. Schepers, G. W. H. 1962. Tuberculous pericarditis. Am. J. Cardiol. 9:248-276.
73. Centers for Disease Control and Prevention, National Institutes of Health. 1988. Biosafety and Biomedical Laboratories. U.S. Government Printing Office, Washington, DC.
74. Fleming, D. O., J. H. Richardson, J. I. Tulis, and D. Vesley. 1995, Laboratory Safety: Principles and Practices, 2nd ed. ASM Press, Washington, DC.
75. Saffinger, M. 1995. Role of the laboratory in evaluating patients with mycobacterial disease. Clin. Microbiol. Newslett. 17:108-111.
76. Willeke, K., and Y. Qian. 1998. Tuberculosis control through respirator wear: performance of National Institute for Occupational Safety and Health-regulated respirators. Am. J. Infect. Control 26:139-142.
77. Decker, M. 1993. OSHA enforcement policy for occupational exposure to tuberculosis. Infect. Control Hosp. Epidemiol. 14:689-693.
78. Dufour, G. 1993. Mycobacteriology. Semin. Pediatr. Infect. Dis. 4:205-213.
79. Shinnick, T., and R. Good. 1995. Diagnostic mycobacteriology laboratory practices. Clin. Infect. Dis. 21:291-299.
80. Pomputius, W., J. Rost, P. H. Dennehy, and E. J. Carter. 1997. Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr. Infect. Dis. J. 16:222-226.
81. Kendig, J. 1993. Pulmonary and pleural tuberculosis. Semin. Ped. Infect. Dis. 4:241-249.
82. Abadco, D. L., and P. Steincr. 1992. Gastric lavage is better than bronchoalveolar lavage for isolation of Mycobacterium tuberculosis in childhood pulmonary tuberculosis. Pediatr. Infect. Dis. J. 11:735-738.
83. Somu, N., S. Swaminathan, C. Paramasivan, D. Vijayasekaran, A. Chandrabhooshanam, V. Vijayan, and R. Prabhakar. 1995. Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuberc. Lung Dis. 76:295-299.
84. Michele, T. M., W. A. Cronin, N. M. H. Graham, D. M. Dwyer, D. S. Pope, S. Harrington, R. E. Chaisson, and W. R. Bishai. 1997. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope: identification by DNA fingerprinting. J.A.M.A. 278:1093-1095.
85. Martin, M. A., and M. Reichelderfer. 1994. APIC guideline for infection prevention and control in flexible endoscopy. Am. J. Infect. Control 22:19-38.
86. Jackson, J., J. E. Leggett, D. Wilson, and D. N. Gilbert. 1996. Mycobaclerium gordonae in fiberoptic bronchoscopes. Am. J. Infect. Control 24:19-23.
87. Marinez-Vazquez, J. M., I. Ocana, I. Ribera, R. M. Segura, and C. Pascual. 1986. Adenosine deaminase activity in the diagnosis of tuberculous peritonitis. Gut 27:1049-1053.
88. Pettersson, T., K. Ojala, and T. H. Weber. 1984. Adenosine deaminase in the diagnosis of pleural effusions. Aact Med. Scand. 215:299-304.
89. Light, R. W. 1983. Pleural Diseases. Lea & Febiger, Philadelphia, PA.
90. Roberts, G. D., E. W. Koneman, and Y. K. Kirn. 1991. Mycobacterium. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken, editors. Manual of Clinical Microbiology, 7th ed. American Society for Microbiology, Washington, DC.
91. Kent, P. T., and G. P. Kubica. 1985. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Centers for Disease Control, Atlanta, GA.
92. Murray, P. 1992. Laboratory diagnosis of mycobacteriosis. In Clinical Microbiology Updates. Hoechst-Roussel Pharmaceuticals, Somerville, NJ.
93. Hobby, G. L., A. P. Holman, M. D. Iseman, and J. Jones. 1973. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob. Agents Chemother. 4:94-104.
94. Yeager, H. J., Jr., J. Lacy, L. Smith, and C. LeMaistre. 1967. Quantitative studies of mycobacterial populations in sputum and saliva. Am. Rev. Respir. Dis. 95:998-1004.
95. Association of State and Territorial Public Health Laboratory Directors and the Centers for Disease Control and Prevention. 1995. Mycobacterium tuberculosis: Assessing Your Laboratory. U.S. Government Printing Office, Washington, DC.
96. Lipsky, G. J., J. Gates, F. C. Tenover, and J. Plorde. 1984. Factors affecting the clinical value for acid-fast bacilli. Rev. Infect. Dis. 6:214-222.
97. Cohen, R., S. Muzaffar, D. Schwartz, S. Bashir, S. Luke, L. McGartland, and K. Kaul. 1998. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am. J. Respir. Crit. Care Med. 157:156-161.
98. Centers for Disease Control and Prevention. 1996. Nucleic acid amplification tests for tuberculosis. MMWR 45:950-952.
99. American Thoracic Society. 1997. Rapid diagnostic tests for tuberculosis: what is the appropriate use? Am. J. Respir. Crit. Care Med. 155: 1804-1814.
100. Catanzaro, A., S. Perry, J. E. Clarridge, S. Dunbar, S. Goodnight-White, P. A. LoBue, C. Peter, G. E. Pfyffer, M. F. Sierra, R. Weber, G. Woods, G. Mathews, V. Jonas, K. Smith, and P. Della-Latta. 2000. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. J.A.M.A. 283:639-645.
101. Perry, S., and A. Catanzaro. 2000. Use of clinical risk assessments in evaluation of nucleic acid amplification tests for HIV/Tuberculosis. Int. J. Tuberc. Lung Dis. 4:534-540.
102. American Thoracic Society. 1997. Rapid diagnostic tests for tuberculosis. What is the appropriate use? Am. J. Respir. Crit. Care Med. 155:1804-1814.
103. Havlir, D. V., and P. F. Barnes. 1999. Tuberculosis in patients with human immunodeficiency virus infection. Curr. Concepts 340:367-373.
104. Morgan, M. A., C. D. Horstmeier, D. R. DeYoung, and G. D. Robers. 1983. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J. Clin. Microbiol. 18:384-388.
105. Ichiyama, S., K. Shimokata, J. Takeuchi, and the AMR Group. 1993. Comparative study of a biphasic culture system (Roche MB check system) with a conventional egg medium for recovery of mycobacteria. Tuberc. Lung Dis. 74:338-341.
106. Starke, J. R. 1988. Modern approach to the diagnosis and management of tuberculosis in children. Pediatr. Clin. North Am. 35:464.
107. Braun, M. 1993. Pediatric tuberculosis, bacille Calmette-Guerin immunization, and acquired immunodeficiency syndrome. Semin. Infect. Dis. 4:261-268.
108. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:S1-S25.
109. Runyon, E. H. 1970. Identification of mycobacterial pathogens utilizing colony characteristics. Am. J. Clin. Pathol. 54:578-586.
110. Butler, W. R., and J. O. Kilburn. 1988. Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high performance liquid chromatography of their mycolic acids. J. Clin. Microbiol. 26:50-53.
111. Hawkins, J. E., R. J. Wallace, and B. A. Brown. 1991. Antibacterial susceptibility tests: mycobacteria. In A. Balows, Jr. and K. L. Herrmann, editors. Manual of Clinical Microbiology. American Society for Microbiology, Washington, DC. 1138-1152.
112. Heifets, L. 1996. Drug susceptibility testing. Clin. Lab. Med. 16:641-656.
113. Inderlied, C., and M. Salfinger. 1999. Antimicrobial agents and susceptibility tests: mycobacteria. In P. R. Murray, E. J. Baron, M. S. Pfaller, F. C. Tenover, and R. H. Yolken, editors. Manual of Clinical Microbiology, 7th ed. American Society for Microbiology, Washington, DC. 1601-1623.
114. Parsons, L. M., J. R. Driscoll, H. W. Taber, and M. Salfinger. 1997. Drug resistance in mycobacteria. Infect. Dis. Clin. North Am. 11: 905-928.
115. van Embden, J., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobactrium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microhiol. 31:406-409.
116. Dunlap, N. E., R. Harris, W. H. Benjamin, Jr., J. Harden, and D. Hafner. 1995. Laboratory contamination of M. tuberculosis (MTB) cultures. Am. J. Respir. Crit. Care Med. 152:1702-1704.
117. Valway, S., M. Sanchez, T. Shinnick, I. Orme, T. Agerton, D. Hoy, J. Jones, H. Westmoreland, and T. Onoralo. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633-639.
118. Behr, M., and P. Small. 1997. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician? Clin. Infect. Dis. 15:806-810.
119. Kimerling, M. E., W. H. Benjamin Jr., K. Lok, G. Curtis, and N. E. Dunlap. 1998. Restriction fragment length polymorphism (RFLP) screening of MTB isolates: population surveillance for targeting disease transmission in a community. Int. J. Tuberc. Lung Dis. 000:00-00.
120. Braden, C., G. Templeton, M. Cave, S. Valway, I. Onorato, K. Castro, D. Moers, Z. Yang, W. Stead, and J. Bates. 1997. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J. Infect. Dis. 175:1446-1452.
121. Daniel, T. M. 1980. The immunology of tuberculosis. Clin. Chest Med. 1:189-201.
122. Seibert, F. B., and J. T. Glenn. 1944. Tuberculin purified protein derivative: preparation and analyses of a large quantity for standard. Am. Rev. Tuberc. 44:9.
123. Sbarbaro, J. A. 1978. Skin test antigens: an evaluation whose time has come. Am. Rev. Respir. Dis. 118:1-5.
124. Edwards, L. B., F. A. Acquaviva, V. T. Livesay, F. W. Cross, and C. E. Palmer. 1969. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 99:1-132.
125. Furcolow, M. L., B. Hewell, W. E. Nelson, and C. E. Palmer. 1941. Quantitative studies of the tuberculin reaction: I. Titration of tuberculin sensitivity and its relation to tuberculous infection. Public Health Rep. 56:1982.
126. Zack, M. B., and L. L. Fulkerson. 1970. Clinical reliability of stabilized and nonstabilized tuberculin PPD. Am. Rev. Respir. Dis. 102:91-93.
127. Tsicopoulos, A., Q. Hamid, V. Varney, S. Ying, R. Moqbel, S. R. Durham, and A. B. Kay. 1992. Preferential messenger RNA expression of Thl-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol. 148:2058-2061.
128. Colvin, R. B., M. W. Mosesson, and H. F. Dvorak. 1979. Delayed-type hypersensitivity skin reactions in congenital afibinogenemia: lack of fibrin deposition and induration. J. Clin. Invest. 63:1302-1306.
129. Robertson, J. M., D. S. Burtt, K. L. Edmonds, P. L. Molina, C. I. Kiefe, and J. J. Ellner. 1996. Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Ann. Intern. Med. 124:779-784.
130. Howard, A., P. Mercer, H. C. Nataraj, and B. C. Kang. 1977. Bevel-down superior to bevel-up in intradermal skin testing. Ann. Allergy Asthma Immunol. 78:594-596.
131. American Thoracic Society. 1981. The tuberculin skin test, 1981. Reprinted from the American Review of Respiratory Diseases. 124: 346-351.
132. Sokal, J.E. 1975. Measurement of delayed skin-test responses. N. Engl. J. Med. 293:501-502.
133. Bouros, D., G. Zeros, C. Panaretos, C. Vassilatos, and N. Siafakas. 1991. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 99:416-419.
134. Holden, M., M. R. Dubin, and P. H. Diamond. 1971. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N. Engl. J. Med. 285:1506-1509.
135. Rooney, J. J., J. A. Croceo, and S. Dramer. 1976. Further observations on tuberculin reactions in active tuberculosis. Am. J. Med. 60:517-522.
136. Bass, J., Jr. 1993. The tuberculin test. In L. Reichman and E. Herschfield, editors. Tuberculosis. Marcel Dekker, New York. 139-148.
137. Advisory Committee on Immunization Practices (ACIP). 1994. General recommendations on immunization. MMVR 43:15.
138. Advisory Committee for Immunization Practices (ACIP). 1989. Measles prevention. MMWR 38:10.
139. American College of Physicians Task Force on Adult Immunization and the Infectious Disease Society of America. 1994. Guide for Adult Immunization, 3rd ed. American College of Physicians, Philadelphia, PA. 7.
140. American Academy of Pediatrics. 1994. Active and passive immunization. In G. Peter, editor. 1994 Red Book: Report of the Committee on Infectious Diseases, 23rd ed. American Academy of Pediatrics, Elk Grove Village, IL. 22.
141. Daniel, T. M., and B. W. Janicki. 1978. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties. Microbiol. Rev. 42:84-113.
142. Harboe, M. 1981. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am. Rev. Respir. Dis. 124:80-87.
143. Centers for Disease Control. 1994. Core Curriculum on Tuberculosis: What the Clinician Should Know, 3rd ed. United States Department of Health and Human Services.
144. Bass, J. B., Jr., and R. A. Serio. 1981. The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am. Rev. Respir. Dis. 123:394-396.
145. Menzies, D. 1991. Interpretation of repeated tuberculin tests. Am. J. Respir. Crit. Care Med. 159:15-21.
146. Shapiro, C, N. Cook, D. Evans, W. Willett, I. Fajardo, D. Koch-Weser, G. Bergonzoli, O. Bolanos, R. Guerrero, and C. H. Hennekens. 1985. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. Int. J. Epidemiol. 14:441-446.
147. Wilson, M. E., H. V. Fineberg, and G. A. Colditz. 1995. Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine. Clin. Infect. Dis. 20:982-991.
148. Fine, P. E. M. 1989. The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. Suppl. 11:S353-S359.
149. Fine, P. E. M. 1988. BCG vaccination against tuberculosis and leprosy. Br. Med. Bull. 44:691-703.
150. Hart, P. I. D. A, I. Sutherland, and J. Thomas. 1967. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variation in induced tuberculin sensitivity and to technical variations in the vaccine. Tubercle 48:201-210.
151. Bretscher, P. A. 1992. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol. Today 13:342-344.
152. Bloom, B. R., and P. E. M. Fine. 1994. The BCG Experience: Implications for future vaccines against tuberculosis. In B. R. Bloom, editor. Tuberculosis: Pathogenesis, Protection, and Control. American Society for Microbiology, Washington, DC. 531-557.
153. Centers for Disease Control and Prevention. 1996. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR 45:RR-4.
154. Graham, N. M. H., K. E. Nelson, L. Solomon, M. Bonds, R. T. Rizzo, J. Scavotto, J. Astemborski, and D. Vlahov. 1992. Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and -seronegative intravenous drug users. J.A.M.A. 267:369-373.
155. Birx, D. L., J. Brundage, K. Larson, R. Engler, L. Smith, E. Squire, et al. 1993. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J. Acquir. Immune Defic. Syndr. 6:1248-1257.
156. Gordin, F. M., P. M. Hartigan, N. G. Klimas, S. B. Zolla-Pazner, M. S. Simberkoff, J. D. Hamilton, et al. 1994. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. J. Infect. Dis. 169:893-897.
157. Centers for Disease Control and Prevention. 1997. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR 46:1-10.
158. Nash, D., and J. E. Douglass. 1980. Anergy in active pulmonary tuberculosis. Chest 77:32-37.
159. Chin, D., D. Osmond, K. Page-Shafer, J. Glassroth, M. Rosen, L. Reichman, P. Kvale, J. Wallace, W. Poole, and P. Hopewell. 1996. Reliability of anergy skin testing in persons with HIV infection. Am. J. Respir. Crit. Care Med. 153:1982-1984.
160. Huebner, R., M. Schein, C. Hall, and S. Barnes. 1994. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis. Clin. Infect. Dis. 19:26-32.
161. Centers for Disease Control and Prevention. 1998. Reported Tuberculosis in the United States, 1997. July 1998.